{"ticker": {"uuid": "5b72fdfd-46fb-4bc8-b338-1c5aa56fea84", "symbol": "2637", "name": "Fujian Haixi Pharmaceuticals Co., Ltd.", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Fujian Haixi Pharma Reshapes Board, Elevates Marketing Chief to Executive Role", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOREdZV29rU0J5WFNud2FET2pBdUY1LTJ3TUlIRmVUNVkwdUswcjhkSXFHMF9TOC1mNS02NEU0QlBKT0hFeTk0N1lCZmFEQXd1QWFkNXBZNFhMVjNKalJsX2ZwVGRJY01XNnc0dzIyQkdDeW5xMXpVRjFJWm9CY0VZN0FnN2RuN2xrU1IwdzlZVjMyWUtUYnZDeHV4Z0VJZC13Nm1WaWRqV1lNV3pFdnhISkt6U0J5TndPWUVmNGRtWWljRUt6VllzVA?oc=5", "source_name": "TipRanks", "published_at": "2026-07-15T11:16:29+00:00", "published_display": "15 Jul 2026 11:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fujian Haixi Pharma Calls 2026 EGM to Approve Auditor Change and New Director", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOVXFia0pzbDE1ZHZLTF8zUy00WkRnY0ZubkhXeFFST25zOGIxSUVtWkhjMThFRjBQcGk3UVlVblg3b2lVYXc1X0RkLXRIcmtaVFNrejRzX21fU09sNmE0RGZrZUphWV82WV9tNF83UmR5dHptZVlIcHptYWJQN0lWbkI5SU5JQWtTd05iSFBRR2lrbmlJd3FRWEpnX1dwQTE2QUxGZkJqVzhBUDZQdU9DMm5HVHZ3TlF4d0FrOEpBRkNucTZrZGFDeQ?oc=5", "source_name": "TipRanks", "published_at": "2026-07-15T11:16:28+00:00", "published_display": "15 Jul 2026 11:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fujian Haixi Pharmaceuticals Sets Formal Nomination Committee to Strengthen Board Governance", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxNS1ltLUJvNVZQbzJ0NzQ1Q1lOZFVzU3ZxSWx5cTQwQ0tpN2YtQkFod3RIcjdaTW1oZTBSV3M3Z2RIYVBwWjNDempWcnZiVHo0cjJHWjYybENvajJlOThZMnJTRzU1VHQtcDBNeVhlZy1QZ1k5TWExZExDLTBTYWhEY0ZycmFiS3RWRWR5MUo3dDl0NzZLcUpWaU83c0FmT09XcWVQeWlsZVlLWHFvdXgzc0hNNWFVQW5xZWtfMHNPM2E1SFNJZ0dldENYMFMtcDVySFFzMURBZldzX05s?oc=5", "source_name": "TipRanks", "published_at": "2026-07-15T11:16:28+00:00", "published_display": "15 Jul 2026 11:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fujian Haixi Pharmaceuticals to Adopt CASBE and Switch Auditor to RSM China", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQQXd1M2ZyQlZBa0UyYS1pMWtEMDlSbjB6Nm1vUmx3Q2NSaW5pLXF0c3RCWW5vMEg0MlRRaEZWVE92a2FpUFZCb0ZGaFJJY1NKbm5LZXRSSm9fQktlRlc3bUZNM0ZsR09OVE1tY29Wcy01NDVfT2ZzdDRMaGI0aVR0ZjFSQ2hnUm5sYkxwTko4bHR0ak1FUlZreF9fWTc4Y0RWbk9rSHBrMWdMczJpTFFBUHJqYzFWQkZVcjlBeUdkMDZRVUNzNHc?oc=5", "source_name": "TipRanks", "published_at": "2026-07-15T10:46:21+00:00", "published_display": "15 Jul 2026 10:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haixi Pharmaceuticals Launches Phase III Trial for Novel Osteosarcoma Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPbXhqWGx1a2ZBTlptTzZGVmw4ZnBlYkhkbEJHT1BVTHFqRkMtZjRzb05iWjlaQlNGd0NkM0VaeTVRLXJZb0NSZEFfbWRpV1E2Smxpc0tzcmhmMGNmbmMxcW5Mc1diNFRERnE4RTFJa1BDb2FBVVZaa0NfM0ZibVNHWXFTb1VfQ3RuVlRJcjNGa2I4MW9pV2NfUFItMUh6MXVON3E1SXVTdXk5YWdtZW9iR1pYQmtwWDNXby1YTmt1VW5JSGlT?oc=5", "source_name": "TipRanks", "published_at": "2026-07-09T09:25:52+00:00", "published_display": "09 Jul 2026 09:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deloitte China assists listing of Haixi Pharma on SEHK", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPdWRULTZDdm5FZ1BQVG5jbHV5MzJJcXFHVFNoeEZLeENGdmIzS3FjYjQwdVdQdUViSzhxNkhXM19PQVcxT3lMck9pX3RRbldpMEtHRU9nT2RUVlVXMlB2RHp1aS14YkU3eWp0SlMwaU9CREtXU2YzUVR1NEFyNkhmUGVlZjZUUElaTW1HbTU3cW5DVW1IYTlmcmlyOUNuRGoxMHJIWUVaNF9QMTA?oc=5", "source_name": "Deloitte", "published_at": "2025-10-20T07:00:00+00:00", "published_display": "20 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FUJIAN HAIXI PHARMACEUTICALS CO., LTD. - H SHARES (2637) - stock price, quote, history", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQaTNPM0g0eU5oYUpVSUgwc3I1VlZlWUFmcS1pTUhYb1ZPWnhqcXFYMTB6MmY2cWZmT0dWOUFaZksxbXVmakRVTW9nVkJMREdCbWZCb1NUdS0yOEZaSHREbGN6WlBIWExLdFpJa0VXSEVIOElZTWM3eTNLV2dFc0t6ZWY2TjYyNHVzVDNBbGx3Zw?oc=5", "source_name": "hkex.com.hk", "published_at": "2025-10-20T07:00:00+00:00", "published_display": "20 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Fujian Haixi Pharma Reshapes Board, Elevates Marketing Chief to Executive Role", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOREdZV29rU0J5WFNud2FET2pBdUY1LTJ3TUlIRmVUNVkwdUswcjhkSXFHMF9TOC1mNS02NEU0QlBKT0hFeTk0N1lCZmFEQXd1QWFkNXBZNFhMVjNKalJsX2ZwVGRJY01XNnc0dzIyQkdDeW5xMXpVRjFJWm9CY0VZN0FnN2RuN2xrU1IwdzlZVjMyWUtUYnZDeHV4Z0VJZC13Nm1WaWRqV1lNV3pFdnhISkt6U0J5TndPWUVmNGRtWWljRUt6VllzVA?oc=5", "source_name": "TipRanks", "published_at": "2026-07-15T11:16:29+00:00", "published_display": "15 Jul 2026 11:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fujian Haixi Pharma Calls 2026 EGM to Approve Auditor Change and New Director", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOVXFia0pzbDE1ZHZLTF8zUy00WkRnY0ZubkhXeFFST25zOGIxSUVtWkhjMThFRjBQcGk3UVlVblg3b2lVYXc1X0RkLXRIcmtaVFNrejRzX21fU09sNmE0RGZrZUphWV82WV9tNF83UmR5dHptZVlIcHptYWJQN0lWbkI5SU5JQWtTd05iSFBRR2lrbmlJd3FRWEpnX1dwQTE2QUxGZkJqVzhBUDZQdU9DMm5HVHZ3TlF4d0FrOEpBRkNucTZrZGFDeQ?oc=5", "source_name": "TipRanks", "published_at": "2026-07-15T11:16:28+00:00", "published_display": "15 Jul 2026 11:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fujian Haixi Pharmaceuticals Sets Formal Nomination Committee to Strengthen Board Governance", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxNS1ltLUJvNVZQbzJ0NzQ1Q1lOZFVzU3ZxSWx5cTQwQ0tpN2YtQkFod3RIcjdaTW1oZTBSV3M3Z2RIYVBwWjNDempWcnZiVHo0cjJHWjYybENvajJlOThZMnJTRzU1VHQtcDBNeVhlZy1QZ1k5TWExZExDLTBTYWhEY0ZycmFiS3RWRWR5MUo3dDl0NzZLcUpWaU83c0FmT09XcWVQeWlsZVlLWHFvdXgzc0hNNWFVQW5xZWtfMHNPM2E1SFNJZ0dldENYMFMtcDVySFFzMURBZldzX05s?oc=5", "source_name": "TipRanks", "published_at": "2026-07-15T11:16:28+00:00", "published_display": "15 Jul 2026 11:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fujian Haixi Pharmaceuticals to Adopt CASBE and Switch Auditor to RSM China", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQQXd1M2ZyQlZBa0UyYS1pMWtEMDlSbjB6Nm1vUmx3Q2NSaW5pLXF0c3RCWW5vMEg0MlRRaEZWVE92a2FpUFZCb0ZGaFJJY1NKbm5LZXRSSm9fQktlRlc3bUZNM0ZsR09OVE1tY29Wcy01NDVfT2ZzdDRMaGI0aVR0ZjFSQ2hnUm5sYkxwTko4bHR0ak1FUlZreF9fWTc4Y0RWbk9rSHBrMWdMczJpTFFBUHJqYzFWQkZVcjlBeUdkMDZRVUNzNHc?oc=5", "source_name": "TipRanks", "published_at": "2026-07-15T10:46:21+00:00", "published_display": "15 Jul 2026 10:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haixi Pharmaceuticals Launches Phase III Trial for Novel Osteosarcoma Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPbXhqWGx1a2ZBTlptTzZGVmw4ZnBlYkhkbEJHT1BVTHFqRkMtZjRzb05iWjlaQlNGd0NkM0VaeTVRLXJZb0NSZEFfbWRpV1E2Smxpc0tzcmhmMGNmbmMxcW5Mc1diNFRERnE4RTFJa1BDb2FBVVZaa0NfM0ZibVNHWXFTb1VfQ3RuVlRJcjNGa2I4MW9pV2NfUFItMUh6MXVON3E1SXVTdXk5YWdtZW9iR1pYQmtwWDNXby1YTmt1VW5JSGlT?oc=5", "source_name": "TipRanks", "published_at": "2026-07-09T09:25:52+00:00", "published_display": "09 Jul 2026 09:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deloitte China assists listing of Haixi Pharma on SEHK", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPdWRULTZDdm5FZ1BQVG5jbHV5MzJJcXFHVFNoeEZLeENGdmIzS3FjYjQwdVdQdUViSzhxNkhXM19PQVcxT3lMck9pX3RRbldpMEtHRU9nT2RUVlVXMlB2RHp1aS14YkU3eWp0SlMwaU9CREtXU2YzUVR1NEFyNkhmUGVlZjZUUElaTW1HbTU3cW5DVW1IYTlmcmlyOUNuRGoxMHJIWUVaNF9QMTA?oc=5", "source_name": "Deloitte", "published_at": "2025-10-20T07:00:00+00:00", "published_display": "20 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FUJIAN HAIXI PHARMACEUTICALS CO., LTD. - H SHARES (2637) - stock price, quote, history", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQaTNPM0g0eU5oYUpVSUgwc3I1VlZlWUFmcS1pTUhYb1ZPWnhqcXFYMTB6MmY2cWZmT0dWOUFaZksxbXVmakRVTW9nVkJMREdCbWZCb1NUdS0yOEZaSHREbGN6WlBIWExLdFpJa0VXSEVIOElZTWM3eTNLV2dFc0t6ZWY2TjYyNHVzVDNBbGx3Zw?oc=5", "source_name": "hkex.com.hk", "published_at": "2025-10-20T07:00:00+00:00", "published_display": "20 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 7, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 7, "score": 50, "total": 7, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 88, "events": [{"event": "general", "label": "Market update", "weight": 3.85, "count": 7}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 205.4, "latest_week": "2026-07-10", "one_week_move": 3.0, "four_week_move": 16.2, "twelve_week_move": 5.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.314872, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": 19.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 41.6667, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.0% over one week, +16.2% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TipRanks", "count": 5}, {"label": "Deloitte", "count": 1}, {"label": "hkex.com.hk", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 7}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 7}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "88/100 classification confidence."}, {"label": "Company focus", "value": "7", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+3.0% over one week, +16.2% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Fujian Haixi Pharma Reshapes Board, Elevates Marketing Chief to Executive Role"}], "updated_at": "2026-07-18T08:11:35.874109+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}